- Home
- MRVI vs BHRB Comparison
MRVI vs BHRB Comparison
Compare MRVI & BHRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRVI | BHRB |
|---|---|---|
| Founded | 2014 | 1852 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 968.8M |
| IPO Year | 2020 | 2023 |
Fundamental Metrics
Financial Performance| Metric | MRVI | BHRB |
|---|---|---|
| Price | $7.72 | $72.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $4.13 | ★ $71.80 |
| AVG Volume (30 Days) | ★ 4.0M | 97.4K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.46% |
| EPS Growth | 14.29 | ★ 173.76 |
| EPS | N/A | ★ 2.16 |
| Revenue | ★ $185,743,000.00 | N/A |
| Revenue This Year | $12.54 | $36.62 |
| Revenue Next Year | $7.87 | $10.06 |
| P/E Ratio | ★ N/A | $33.16 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.29 | $57.42 |
| 52 Week High | $9.42 | $75.09 |
Technical Indicators
Market Signals| Indicator | MRVI | BHRB |
|---|---|---|
| Relative Strength Index (RSI) | 60.70 | 49.90 |
| Support Level | $5.37 | $68.38 |
| Resistance Level | N/A | $73.55 |
| Average True Range (ATR) | 0.51 | 1.34 |
| MACD | 0.20 | -0.24 |
| Stochastic Oscillator | 63.37 | 41.74 |
Price Performance
Historical ComparisonAbout MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
About BHRB Burke & Herbert Financial Services Corp.
Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.